J PHARMACEUT BIOMED 润色咨询

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

出版年份:1983 年文章数:7374 投稿命中率: 开通期刊会员,数据随心看

出版周期:Semimonthly 自引率:10.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=562548, encodeId=4abb562548c8, content=文章是中药复方灌胃,治疗心衰大鼠,观察对神经的治疗作用,检测神经因子,经过PCI/wb/IF验证,可以发这个杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70cf1926894, createdName=Longerstar, createdTime=Tue Oct 30 16:02:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123783, encodeId=77882123e836e, content=偏重的研究方向:分析方法<br>经验分享:三个审稿人,2个小修,一个拒稿(创新性不佳),编辑给的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c9b5435557, createdName=ms2000000150091139, createdTime=Tue Apr 04 23:29:42 CST 2023, time=2023-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=955831, encodeId=15b59558315e, content=3月3号投的高分辨质谱做代谢组学,一审还没回来,等着今年评职称呢?不晓得好久回来,得不得遭拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4765479177, createdName=ms7000000413681128, createdTime=Sun Apr 11 08:39:53 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113405, encodeId=28ab2113405ac, content=接收综述类的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e9b8359206, createdName=ms4000000556849805, createdTime=Tue Feb 07 11:08:20 CST 2023, time=2023-02-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=557695, encodeId=3c2355e6955b, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:2018-3-37投稿,大概一个多星期进入Under Review ,现在还是Under Review,两个多月了,各位大神,选的哪个审稿人速度回快点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5432365650, createdName=122e0bc0m94(暂无昵称), createdTime=Thu Jun 07 11:31:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579160, encodeId=9ce45e91604e, content=under review快三个月了,有没有人最近投稿啊,也是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78475219108, createdName=14777073m21(暂无昵称), createdTime=Fri Nov 01 09:23:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093922, encodeId=7ac31093922d4, content=讨论的字数一般控制在多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093921, encodeId=7cdf10939217a, content=想要做但未做的实验是否可以放到讨论中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564213, encodeId=eab456421384, content=你好,请问上传原始数据了吗,谢谢<span class="quote">189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表:<br>3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。 <br> 这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……</span>, beContent=189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表: 3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。 <br> 这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587641, encodeId=d16558e6417c, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:杂志很快的,效率还是挺高的,2个月审稿结束,修改,再提交后,半个月接收,直接online了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9551635768, createdName=JXQJ, createdTime=Sat Mar 28 16:38:00 CST 2020, time=2020-03-28, status=1, ipAttribution=)]
    2018-10-30 Longerstar

    文章是中药复方灌胃,治疗心衰大鼠,观察对神经的治疗作用,检测神经因子,经过PCI/wb/IF验证,可以发这个杂志吗

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=562548, encodeId=4abb562548c8, content=文章是中药复方灌胃,治疗心衰大鼠,观察对神经的治疗作用,检测神经因子,经过PCI/wb/IF验证,可以发这个杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70cf1926894, createdName=Longerstar, createdTime=Tue Oct 30 16:02:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123783, encodeId=77882123e836e, content=偏重的研究方向:分析方法<br>经验分享:三个审稿人,2个小修,一个拒稿(创新性不佳),编辑给的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c9b5435557, createdName=ms2000000150091139, createdTime=Tue Apr 04 23:29:42 CST 2023, time=2023-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=955831, encodeId=15b59558315e, content=3月3号投的高分辨质谱做代谢组学,一审还没回来,等着今年评职称呢?不晓得好久回来,得不得遭拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4765479177, createdName=ms7000000413681128, createdTime=Sun Apr 11 08:39:53 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113405, encodeId=28ab2113405ac, content=接收综述类的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e9b8359206, createdName=ms4000000556849805, createdTime=Tue Feb 07 11:08:20 CST 2023, time=2023-02-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=557695, encodeId=3c2355e6955b, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:2018-3-37投稿,大概一个多星期进入Under Review ,现在还是Under Review,两个多月了,各位大神,选的哪个审稿人速度回快点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5432365650, createdName=122e0bc0m94(暂无昵称), createdTime=Thu Jun 07 11:31:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579160, encodeId=9ce45e91604e, content=under review快三个月了,有没有人最近投稿啊,也是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78475219108, createdName=14777073m21(暂无昵称), createdTime=Fri Nov 01 09:23:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093922, encodeId=7ac31093922d4, content=讨论的字数一般控制在多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093921, encodeId=7cdf10939217a, content=想要做但未做的实验是否可以放到讨论中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564213, encodeId=eab456421384, content=你好,请问上传原始数据了吗,谢谢<span class="quote">189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表:<br>3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。 <br> 这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……</span>, beContent=189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表: 3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。 <br> 这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587641, encodeId=d16558e6417c, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:杂志很快的,效率还是挺高的,2个月审稿结束,修改,再提交后,半个月接收,直接online了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9551635768, createdName=JXQJ, createdTime=Sat Mar 28 16:38:00 CST 2020, time=2020-03-28, status=1, ipAttribution=)]
    2023-04-04 ms2000000150091139 来自上海

    偏重的研究方向:分析方法
    经验分享:三个审稿人,2个小修,一个拒稿(创新性不佳),编辑给的拒稿。

    5

    展开5条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=562548, encodeId=4abb562548c8, content=文章是中药复方灌胃,治疗心衰大鼠,观察对神经的治疗作用,检测神经因子,经过PCI/wb/IF验证,可以发这个杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70cf1926894, createdName=Longerstar, createdTime=Tue Oct 30 16:02:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123783, encodeId=77882123e836e, content=偏重的研究方向:分析方法<br>经验分享:三个审稿人,2个小修,一个拒稿(创新性不佳),编辑给的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c9b5435557, createdName=ms2000000150091139, createdTime=Tue Apr 04 23:29:42 CST 2023, time=2023-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=955831, encodeId=15b59558315e, content=3月3号投的高分辨质谱做代谢组学,一审还没回来,等着今年评职称呢?不晓得好久回来,得不得遭拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4765479177, createdName=ms7000000413681128, createdTime=Sun Apr 11 08:39:53 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113405, encodeId=28ab2113405ac, content=接收综述类的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e9b8359206, createdName=ms4000000556849805, createdTime=Tue Feb 07 11:08:20 CST 2023, time=2023-02-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=557695, encodeId=3c2355e6955b, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:2018-3-37投稿,大概一个多星期进入Under Review ,现在还是Under Review,两个多月了,各位大神,选的哪个审稿人速度回快点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5432365650, createdName=122e0bc0m94(暂无昵称), createdTime=Thu Jun 07 11:31:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579160, encodeId=9ce45e91604e, content=under review快三个月了,有没有人最近投稿啊,也是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78475219108, createdName=14777073m21(暂无昵称), createdTime=Fri Nov 01 09:23:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093922, encodeId=7ac31093922d4, content=讨论的字数一般控制在多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093921, encodeId=7cdf10939217a, content=想要做但未做的实验是否可以放到讨论中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564213, encodeId=eab456421384, content=你好,请问上传原始数据了吗,谢谢<span class="quote">189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表:<br>3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。 <br> 这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……</span>, beContent=189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表: 3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。 <br> 这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587641, encodeId=d16558e6417c, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:杂志很快的,效率还是挺高的,2个月审稿结束,修改,再提交后,半个月接收,直接online了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9551635768, createdName=JXQJ, createdTime=Sat Mar 28 16:38:00 CST 2020, time=2020-03-28, status=1, ipAttribution=)]
    2021-04-11 ms7000000413681128

    3月3号投的高分辨质谱做代谢组学,一审还没回来,等着今年评职称呢?不晓得好久回来,得不得遭拒?

    9

    展开9条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=562548, encodeId=4abb562548c8, content=文章是中药复方灌胃,治疗心衰大鼠,观察对神经的治疗作用,检测神经因子,经过PCI/wb/IF验证,可以发这个杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70cf1926894, createdName=Longerstar, createdTime=Tue Oct 30 16:02:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123783, encodeId=77882123e836e, content=偏重的研究方向:分析方法<br>经验分享:三个审稿人,2个小修,一个拒稿(创新性不佳),编辑给的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c9b5435557, createdName=ms2000000150091139, createdTime=Tue Apr 04 23:29:42 CST 2023, time=2023-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=955831, encodeId=15b59558315e, content=3月3号投的高分辨质谱做代谢组学,一审还没回来,等着今年评职称呢?不晓得好久回来,得不得遭拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4765479177, createdName=ms7000000413681128, createdTime=Sun Apr 11 08:39:53 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113405, encodeId=28ab2113405ac, content=接收综述类的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e9b8359206, createdName=ms4000000556849805, createdTime=Tue Feb 07 11:08:20 CST 2023, time=2023-02-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=557695, encodeId=3c2355e6955b, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:2018-3-37投稿,大概一个多星期进入Under Review ,现在还是Under Review,两个多月了,各位大神,选的哪个审稿人速度回快点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5432365650, createdName=122e0bc0m94(暂无昵称), createdTime=Thu Jun 07 11:31:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579160, encodeId=9ce45e91604e, content=under review快三个月了,有没有人最近投稿啊,也是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78475219108, createdName=14777073m21(暂无昵称), createdTime=Fri Nov 01 09:23:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093922, encodeId=7ac31093922d4, content=讨论的字数一般控制在多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093921, encodeId=7cdf10939217a, content=想要做但未做的实验是否可以放到讨论中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564213, encodeId=eab456421384, content=你好,请问上传原始数据了吗,谢谢<span class="quote">189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表:<br>3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。 <br> 这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……</span>, beContent=189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表: 3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。 <br> 这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587641, encodeId=d16558e6417c, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:杂志很快的,效率还是挺高的,2个月审稿结束,修改,再提交后,半个月接收,直接online了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9551635768, createdName=JXQJ, createdTime=Sat Mar 28 16:38:00 CST 2020, time=2020-03-28, status=1, ipAttribution=)]
    2023-02-07 ms4000000556849805 来自四川省

    接收综述类的吗

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=562548, encodeId=4abb562548c8, content=文章是中药复方灌胃,治疗心衰大鼠,观察对神经的治疗作用,检测神经因子,经过PCI/wb/IF验证,可以发这个杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70cf1926894, createdName=Longerstar, createdTime=Tue Oct 30 16:02:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123783, encodeId=77882123e836e, content=偏重的研究方向:分析方法<br>经验分享:三个审稿人,2个小修,一个拒稿(创新性不佳),编辑给的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c9b5435557, createdName=ms2000000150091139, createdTime=Tue Apr 04 23:29:42 CST 2023, time=2023-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=955831, encodeId=15b59558315e, content=3月3号投的高分辨质谱做代谢组学,一审还没回来,等着今年评职称呢?不晓得好久回来,得不得遭拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4765479177, createdName=ms7000000413681128, createdTime=Sun Apr 11 08:39:53 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113405, encodeId=28ab2113405ac, content=接收综述类的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e9b8359206, createdName=ms4000000556849805, createdTime=Tue Feb 07 11:08:20 CST 2023, time=2023-02-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=557695, encodeId=3c2355e6955b, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:2018-3-37投稿,大概一个多星期进入Under Review ,现在还是Under Review,两个多月了,各位大神,选的哪个审稿人速度回快点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5432365650, createdName=122e0bc0m94(暂无昵称), createdTime=Thu Jun 07 11:31:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579160, encodeId=9ce45e91604e, content=under review快三个月了,有没有人最近投稿啊,也是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78475219108, createdName=14777073m21(暂无昵称), createdTime=Fri Nov 01 09:23:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093922, encodeId=7ac31093922d4, content=讨论的字数一般控制在多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093921, encodeId=7cdf10939217a, content=想要做但未做的实验是否可以放到讨论中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564213, encodeId=eab456421384, content=你好,请问上传原始数据了吗,谢谢<span class="quote">189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表:<br>3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。 <br> 这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……</span>, beContent=189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表: 3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。 <br> 这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587641, encodeId=d16558e6417c, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:杂志很快的,效率还是挺高的,2个月审稿结束,修改,再提交后,半个月接收,直接online了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9551635768, createdName=JXQJ, createdTime=Sat Mar 28 16:38:00 CST 2020, time=2020-03-28, status=1, ipAttribution=)]
    2018-06-07 122e0bc0m94(暂无昵称)

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享:2018-3-37投稿,大概一个多星期进入Under Review ,现在还是Under Review,两个多月了,各位大神,选的哪个审稿人速度回快点啊

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=562548, encodeId=4abb562548c8, content=文章是中药复方灌胃,治疗心衰大鼠,观察对神经的治疗作用,检测神经因子,经过PCI/wb/IF验证,可以发这个杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70cf1926894, createdName=Longerstar, createdTime=Tue Oct 30 16:02:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123783, encodeId=77882123e836e, content=偏重的研究方向:分析方法<br>经验分享:三个审稿人,2个小修,一个拒稿(创新性不佳),编辑给的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c9b5435557, createdName=ms2000000150091139, createdTime=Tue Apr 04 23:29:42 CST 2023, time=2023-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=955831, encodeId=15b59558315e, content=3月3号投的高分辨质谱做代谢组学,一审还没回来,等着今年评职称呢?不晓得好久回来,得不得遭拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4765479177, createdName=ms7000000413681128, createdTime=Sun Apr 11 08:39:53 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113405, encodeId=28ab2113405ac, content=接收综述类的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e9b8359206, createdName=ms4000000556849805, createdTime=Tue Feb 07 11:08:20 CST 2023, time=2023-02-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=557695, encodeId=3c2355e6955b, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:2018-3-37投稿,大概一个多星期进入Under Review ,现在还是Under Review,两个多月了,各位大神,选的哪个审稿人速度回快点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5432365650, createdName=122e0bc0m94(暂无昵称), createdTime=Thu Jun 07 11:31:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579160, encodeId=9ce45e91604e, content=under review快三个月了,有没有人最近投稿啊,也是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78475219108, createdName=14777073m21(暂无昵称), createdTime=Fri Nov 01 09:23:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093922, encodeId=7ac31093922d4, content=讨论的字数一般控制在多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093921, encodeId=7cdf10939217a, content=想要做但未做的实验是否可以放到讨论中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564213, encodeId=eab456421384, content=你好,请问上传原始数据了吗,谢谢<span class="quote">189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表:<br>3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。 <br> 这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……</span>, beContent=189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表: 3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。 <br> 这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587641, encodeId=d16558e6417c, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:杂志很快的,效率还是挺高的,2个月审稿结束,修改,再提交后,半个月接收,直接online了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9551635768, createdName=JXQJ, createdTime=Sat Mar 28 16:38:00 CST 2020, time=2020-03-28, status=1, ipAttribution=)]
    2019-11-01 14777073m21(暂无昵称)

    under review快三个月了,有没有人最近投稿啊,也是这种情况吗

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=562548, encodeId=4abb562548c8, content=文章是中药复方灌胃,治疗心衰大鼠,观察对神经的治疗作用,检测神经因子,经过PCI/wb/IF验证,可以发这个杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70cf1926894, createdName=Longerstar, createdTime=Tue Oct 30 16:02:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123783, encodeId=77882123e836e, content=偏重的研究方向:分析方法<br>经验分享:三个审稿人,2个小修,一个拒稿(创新性不佳),编辑给的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c9b5435557, createdName=ms2000000150091139, createdTime=Tue Apr 04 23:29:42 CST 2023, time=2023-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=955831, encodeId=15b59558315e, content=3月3号投的高分辨质谱做代谢组学,一审还没回来,等着今年评职称呢?不晓得好久回来,得不得遭拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4765479177, createdName=ms7000000413681128, createdTime=Sun Apr 11 08:39:53 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113405, encodeId=28ab2113405ac, content=接收综述类的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e9b8359206, createdName=ms4000000556849805, createdTime=Tue Feb 07 11:08:20 CST 2023, time=2023-02-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=557695, encodeId=3c2355e6955b, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:2018-3-37投稿,大概一个多星期进入Under Review ,现在还是Under Review,两个多月了,各位大神,选的哪个审稿人速度回快点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5432365650, createdName=122e0bc0m94(暂无昵称), createdTime=Thu Jun 07 11:31:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579160, encodeId=9ce45e91604e, content=under review快三个月了,有没有人最近投稿啊,也是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78475219108, createdName=14777073m21(暂无昵称), createdTime=Fri Nov 01 09:23:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093922, encodeId=7ac31093922d4, content=讨论的字数一般控制在多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093921, encodeId=7cdf10939217a, content=想要做但未做的实验是否可以放到讨论中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564213, encodeId=eab456421384, content=你好,请问上传原始数据了吗,谢谢<span class="quote">189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表:<br>3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。 <br> 这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……</span>, beContent=189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表: 3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。 <br> 这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587641, encodeId=d16558e6417c, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:杂志很快的,效率还是挺高的,2个月审稿结束,修改,再提交后,半个月接收,直接online了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9551635768, createdName=JXQJ, createdTime=Sat Mar 28 16:38:00 CST 2020, time=2020-03-28, status=1, ipAttribution=)]
    2021-12-27 衣谷

    讨论的字数一般控制在多少?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=562548, encodeId=4abb562548c8, content=文章是中药复方灌胃,治疗心衰大鼠,观察对神经的治疗作用,检测神经因子,经过PCI/wb/IF验证,可以发这个杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70cf1926894, createdName=Longerstar, createdTime=Tue Oct 30 16:02:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123783, encodeId=77882123e836e, content=偏重的研究方向:分析方法<br>经验分享:三个审稿人,2个小修,一个拒稿(创新性不佳),编辑给的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c9b5435557, createdName=ms2000000150091139, createdTime=Tue Apr 04 23:29:42 CST 2023, time=2023-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=955831, encodeId=15b59558315e, content=3月3号投的高分辨质谱做代谢组学,一审还没回来,等着今年评职称呢?不晓得好久回来,得不得遭拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4765479177, createdName=ms7000000413681128, createdTime=Sun Apr 11 08:39:53 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113405, encodeId=28ab2113405ac, content=接收综述类的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e9b8359206, createdName=ms4000000556849805, createdTime=Tue Feb 07 11:08:20 CST 2023, time=2023-02-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=557695, encodeId=3c2355e6955b, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:2018-3-37投稿,大概一个多星期进入Under Review ,现在还是Under Review,两个多月了,各位大神,选的哪个审稿人速度回快点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5432365650, createdName=122e0bc0m94(暂无昵称), createdTime=Thu Jun 07 11:31:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579160, encodeId=9ce45e91604e, content=under review快三个月了,有没有人最近投稿啊,也是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78475219108, createdName=14777073m21(暂无昵称), createdTime=Fri Nov 01 09:23:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093922, encodeId=7ac31093922d4, content=讨论的字数一般控制在多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093921, encodeId=7cdf10939217a, content=想要做但未做的实验是否可以放到讨论中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564213, encodeId=eab456421384, content=你好,请问上传原始数据了吗,谢谢<span class="quote">189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表:<br>3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。 <br> 这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……</span>, beContent=189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表: 3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。 <br> 这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587641, encodeId=d16558e6417c, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:杂志很快的,效率还是挺高的,2个月审稿结束,修改,再提交后,半个月接收,直接online了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9551635768, createdName=JXQJ, createdTime=Sat Mar 28 16:38:00 CST 2020, time=2020-03-28, status=1, ipAttribution=)]
    2021-12-27 小动量

    想要做但未做的实验是否可以放到讨论中?

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=562548, encodeId=4abb562548c8, content=文章是中药复方灌胃,治疗心衰大鼠,观察对神经的治疗作用,检测神经因子,经过PCI/wb/IF验证,可以发这个杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70cf1926894, createdName=Longerstar, createdTime=Tue Oct 30 16:02:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123783, encodeId=77882123e836e, content=偏重的研究方向:分析方法<br>经验分享:三个审稿人,2个小修,一个拒稿(创新性不佳),编辑给的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c9b5435557, createdName=ms2000000150091139, createdTime=Tue Apr 04 23:29:42 CST 2023, time=2023-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=955831, encodeId=15b59558315e, content=3月3号投的高分辨质谱做代谢组学,一审还没回来,等着今年评职称呢?不晓得好久回来,得不得遭拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4765479177, createdName=ms7000000413681128, createdTime=Sun Apr 11 08:39:53 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113405, encodeId=28ab2113405ac, content=接收综述类的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e9b8359206, createdName=ms4000000556849805, createdTime=Tue Feb 07 11:08:20 CST 2023, time=2023-02-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=557695, encodeId=3c2355e6955b, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:2018-3-37投稿,大概一个多星期进入Under Review ,现在还是Under Review,两个多月了,各位大神,选的哪个审稿人速度回快点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5432365650, createdName=122e0bc0m94(暂无昵称), createdTime=Thu Jun 07 11:31:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579160, encodeId=9ce45e91604e, content=under review快三个月了,有没有人最近投稿啊,也是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78475219108, createdName=14777073m21(暂无昵称), createdTime=Fri Nov 01 09:23:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093922, encodeId=7ac31093922d4, content=讨论的字数一般控制在多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093921, encodeId=7cdf10939217a, content=想要做但未做的实验是否可以放到讨论中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564213, encodeId=eab456421384, content=你好,请问上传原始数据了吗,谢谢<span class="quote">189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表:<br>3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。 <br> 这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……</span>, beContent=189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表: 3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。 <br> 这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587641, encodeId=d16558e6417c, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:杂志很快的,效率还是挺高的,2个月审稿结束,修改,再提交后,半个月接收,直接online了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9551635768, createdName=JXQJ, createdTime=Sat Mar 28 16:38:00 CST 2020, time=2020-03-28, status=1, ipAttribution=)]
    2018-12-09 rongshi56

    你好,请问上传原始数据了吗,谢谢189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表:
    3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。
    这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……

    189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表: 3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。
    这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=562548, encodeId=4abb562548c8, content=文章是中药复方灌胃,治疗心衰大鼠,观察对神经的治疗作用,检测神经因子,经过PCI/wb/IF验证,可以发这个杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70cf1926894, createdName=Longerstar, createdTime=Tue Oct 30 16:02:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123783, encodeId=77882123e836e, content=偏重的研究方向:分析方法<br>经验分享:三个审稿人,2个小修,一个拒稿(创新性不佳),编辑给的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c9b5435557, createdName=ms2000000150091139, createdTime=Tue Apr 04 23:29:42 CST 2023, time=2023-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=955831, encodeId=15b59558315e, content=3月3号投的高分辨质谱做代谢组学,一审还没回来,等着今年评职称呢?不晓得好久回来,得不得遭拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4765479177, createdName=ms7000000413681128, createdTime=Sun Apr 11 08:39:53 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113405, encodeId=28ab2113405ac, content=接收综述类的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e9b8359206, createdName=ms4000000556849805, createdTime=Tue Feb 07 11:08:20 CST 2023, time=2023-02-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=557695, encodeId=3c2355e6955b, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:2018-3-37投稿,大概一个多星期进入Under Review ,现在还是Under Review,两个多月了,各位大神,选的哪个审稿人速度回快点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5432365650, createdName=122e0bc0m94(暂无昵称), createdTime=Thu Jun 07 11:31:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579160, encodeId=9ce45e91604e, content=under review快三个月了,有没有人最近投稿啊,也是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78475219108, createdName=14777073m21(暂无昵称), createdTime=Fri Nov 01 09:23:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093922, encodeId=7ac31093922d4, content=讨论的字数一般控制在多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093921, encodeId=7cdf10939217a, content=想要做但未做的实验是否可以放到讨论中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564213, encodeId=eab456421384, content=你好,请问上传原始数据了吗,谢谢<span class="quote">189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表:<br>3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。 <br> 这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……</span>, beContent=189cRLa6508(暂无昵称) 2018-07-20 08:51:00 发表: 3月底投稿,一审45天左右,大修。两个审稿人,提了不少有意义的审稿意见,尤其方法学验证这一块,需要严格参照FDA的生物样品检测方法。修稿2个月,修回后3天接收。 <br> 这是本人自己申请课题,从设计实验、申报课题、伦理审查、开题中期答辩、开展试验、论文撰写、校对、投稿、修稿都是我自己搞定的第一篇SCI文章,混科研不容易……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587641, encodeId=d16558e6417c, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:杂志很快的,效率还是挺高的,2个月审稿结束,修改,再提交后,半个月接收,直接online了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9551635768, createdName=JXQJ, createdTime=Sat Mar 28 16:38:00 CST 2020, time=2020-03-28, status=1, ipAttribution=)]
    2020-03-28 JXQJ

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享:杂志很快的,效率还是挺高的,2个月审稿结束,修改,再提交后,半个月接收,直接online了。

    5

    展开5条回复
共129条页码: 1/13页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分